Who Owns MREO?

Mereo BioPharma Group plc — Institutional Ownership & 13F Holdings

$0.28

-0.02 (-5.21%)

Market Cap

$62.5M

Shares Outstanding

159,615,766

Institutional Holders

89

Total Inst. Value

$606.2M

% of Float Held

QoQ Holder Change

+21

Institutional data as of Q1 2025

New Positions

13

Closed Positions

14

Increased

29

Decreased

20

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1DEERFIELD MANAGEMENT COMPANY, L.P.$422.8M187,892,012
2Rubric Capital Management LP$34.4M15,307,347
3MANGROVE PARTNERS IM, LLC$19.4M8,636,485
4Frazier Life Sciences Management, L.P.$17.6M7,819,863
5Rock Springs Capital Management LP$15.0M6,684,247
6ALKEON CAPITAL MANAGEMENT LLC$10.6M4,698,100
7683 Capital Management, LLC$10.4M4,635,000
8GAMMA Investing LLC$8.4M18,855
9Clearline Capital LP$7.2M3,217,894
10Tejara Capital Ltd$5.7M2,521,324

Biggest Buyers & Sellers This Quarter

Top Sellers

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold MREO?

As of Q1 2025, 89 institutional investors report holding MREO (Mereo BioPharma Group plc) in their 13F filings.

Which hedge fund owns the most MREO?

The largest institutional holder of MREO is DEERFIELD MANAGEMENT COMPANY, L.P. with $422.8M in shares.

Are institutions buying or selling MREO?

This quarter, 13 institutions opened new positions in MREO and 14 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.